Literature DB >> 33794296

HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Susmita Sil1, Annadurai Thangaraj1, Ernest T Chivero1, Fang Niu1, Muthukumar Kannan1, Ke Liao1, Peter S Silverstein2, Palsamy Periyasamy3, Shilpa Buch4.   

Abstract

Various research studies that have investigated the association between HIV infection and addiction underpin the role of various drugs of abuse in impairing immunological and non-immunological pathways of the host system, ultimately leading to augmentation of HIV infection and disease progression. These studies have included both in vitro and in vivo animal models wherein investigators have assessed the effects of various drugs on several disease parameters to decipher the impact of drugs on both HIV infection and progression of HIV-associated neurocognitive disorders (HAND). However, given the inherent limitations in the existing animal models of HAND, these investigations only recapitulated specific aspects of the disease but not the complex human syndrome. Despite the inability of HIV to infect rodents over the last 30 years, multiple strategies have been employed to develop several rodent models of HAND. While none of these models can accurately mimic the overall pathophysiology of HAND, they serve the purpose of modeling some unique aspects of HAND. This review provides an overview of various animal models used in the field and a careful evaluation of methodological strengths and limitations inherent in both the model systems and study designs to understand better how the various animal models complement one another. Published by Elsevier B.V.

Entities:  

Keywords:  Animal models; Drug abuse; HAND; HIV; Rhesus macaques; SIV

Mesh:

Year:  2021        PMID: 33794296      PMCID: PMC8108725          DOI: 10.1016/j.neulet.2021.135863

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.197


  374 in total

1.  The effects of doxycycline administration on amino acid neurotransmitters in an animal model of neonatal hypoxia-ischemia.

Authors:  Lauren L Jantzie; Gail A Rauw; Kathryn G Todd
Journal:  Neurochem Int       Date:  2006-08-17       Impact factor: 3.921

2.  Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.

Authors:  M-J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Andrea Krusi; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

Review 3.  Searching for clues: tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model.

Authors:  Joseph L Mankowski; Janice E Clements; M Christine Zink
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

4.  Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection.

Authors:  M C Marcondes; E M Burudi; S Huitron-Resendiz; M Sanchez-Alavez; D Watry; M Zandonatti; S J Henriksen; H S Fox
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

Review 5.  SIV infected rhesus macaques: an AIDS model for immunoprevention and immunotherapy.

Authors:  M B Gardner
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

Review 6.  Monocyte/macrophages and their role in HIV neuropathogenesis.

Authors:  Tricia H Burdo; Andrew Lackner; Kenneth C Williams
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

7.  The severe combined immunodeficient (SCID) mouse model of human immunodeficiency virus encephalitis: deficits in cognitive function.

Authors:  William C Griffin; Lawrence D Middaugh; Jennifer E Cook; William R Tyor
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

8.  Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice.

Authors:  Jason J Paris; Amanda N Carey; Christopher F Shay; Stacey M Gomes; Johnny J He; Jay P McLaughlin
Journal:  Neuropsychopharmacology       Date:  2013-08-15       Impact factor: 7.853

9.  Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice.

Authors:  Michael D Boska; Prasanta K Dash; Jaclyn Knibbe; Adrian A Epstein; Sidra P Akhter; Natasha Fields; Robin High; Edward Makarov; Stephen Bonasera; Harris A Gelbard; Larisa Y Poluektova; Howard E Gendelman; Santhi Gorantla
Journal:  Mol Neurodegener       Date:  2014-12-18       Impact factor: 14.195

10.  HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model.

Authors:  Jenna B Honeycutt; Angela Wahl; Nancie Archin; Shailesh Choudhary; David Margolis; J Victor Garcia
Journal:  Retrovirology       Date:  2013-10-24       Impact factor: 4.602

View more
  1 in total

1.  Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats.

Authors:  Chiomah Ezeomah; Chanida Fongsaran; Amanda L Persons; T Celeste Napier; Irma E Cisneros
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.